<DOC>
	<DOCNO>NCT00411619</DOCNO>
	<brief_summary>The purpose study evaluate safety potential side effect everolimus ( experimental drug ) person Tuberous Sclerosis Complex also diagnose brain tumor ( astrocytoma ) The hypothesis drug cause tumor size decrease , may beneficial activity separate effect tumor patient .</brief_summary>
	<brief_title>Everolimus ( RAD001 ) Therapy Giant Cell Astrocytoma Patients With Tuberous Sclerosis Complex</brief_title>
	<detailed_description>Tuberous Sclerosis Complex ( TSC ) genetic disorder birth incidence approximately one six thousand . Five twenty percent patient TSC develop astrocytoma , slowly progressive tumor . They grow cause damage surround brain tissue , blockage spinal fluid ( hydrocephalus ) , blindness , trouble walking , seizure , brain damage . If untreated , fatal . Standard treatment involve surgery remove tumor ; however surgery may cause brain damage , bleeding , infection , well complication . Studies show everolimus suppresses chemical cause tumor grow tuberous sclerosis , may cause shrink . The primary objective study find effect everolimus astrocytomas six month trial patient Tuberous Sclerosis diagnose astrocytoma</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Astrocytoma</mesh_term>
	<mesh_term>Tuberous Sclerosis</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Age three year older If female child bear potential , documentation negative pregnancy test prior enrollment . In extension phase , females child bear potential require take monthly home pregnancy test record result provide diary card . Clinically definite diagnosis tuberous sclerosis ( modify Gomez criterion positive genetic test ) Presence giant cell astrocytoma define image characteristic serial increase size lesion 2 MRI scan Adequate renal function ( creatinine &lt; 1.5 mg/dl ) Serious intercurrent medical illness uncontrolled medical disease could compromise participation study Significant hematologic hepatic abnormality Continuous requirement supplemental oxygen Intercurrent infection initiation everolimus Embolization angiomyolipoma within one month ; recent surgery within 2 month initiation everolimus Pregnant lactate woman Use investigational drug within last 30 day Must adequately recover acute toxicity prior therapy Clinical evidence impend herniation focal neurologic deficit relate subject 's astrocytoma Unwilling unable use highly effective contraception</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Tuberous Sclerosis Complex ( TSC )</keyword>
	<keyword>Subendymal Giant Cell Astrocytomas ( SEGA 'S )</keyword>
	<keyword>Mammalian Target Rapamycin ( mTOR )</keyword>
	<keyword>Everolimus ( RAD001 )</keyword>
	<keyword>Tuberous Sclerosis Subependymal Giant Cell Astrocytomas</keyword>
</DOC>